Literature DB >> 24002671

Cellular and molecular mechanisms of endothelial dysfunction in diabetes.

Anna C Roberts1, Karen E Porter.   

Abstract

In healthy individuals, the vascular endothelium regulates an intricate balance of factors that maintain vascular homeostasis and normal arterial function. Functional disruption of the endothelium is known to be an early event that underlies the development of subsequent cardiovascular disease (CVD) including atherosclerosis and coronary heart disease. In addition, the rising global epidemic of type 2 diabetes is a significant problem conferring a significantly higher risk of CVD to individuals in whom endothelial dysfunction is also notable. This review first summarises the role of endothelium in health and explores and evaluates the impact of diabetes on endothelial function. The characteristic features of insulin resistance and other metabolic disturbances that may underlie long-term changes in vascular endothelial function (metabolic memory) are described along with proposed cellular, molecular and epigenetic mechanisms. Through understanding the underlying mechanisms, novel targets for future therapies to restore endothelial homeostasis and 'drive' a reparative cellular phenotype are explored.

Entities:  

Keywords:  Diabetes; endothelial dysfunction; endothelial function; metabolic memory; microRNA; novel therapies

Mesh:

Substances:

Year:  2013        PMID: 24002671     DOI: 10.1177/1479164113500680

Source DB:  PubMed          Journal:  Diab Vasc Dis Res        ISSN: 1479-1641            Impact factor:   3.291


  65 in total

Review 1.  Vascular Smooth Muscle as a Target for Novel Therapeutics.

Authors:  Karen E Porter; Kirsten Riches
Journal:  Curr Diab Rep       Date:  2015-10       Impact factor: 4.810

Review 2.  Closing the Loop.

Authors:  Revital Nimri; Nathan Murray; Alexander Ochs; Jordan E Pinsker; Eyal Dassau
Journal:  Diabetes Technol Ther       Date:  2017-02       Impact factor: 6.118

Review 3.  Prognostic value of endothelial dysfunction in type 1 diabetes mellitus.

Authors:  Ana Marice Ladeia; Raphael Ribeiro Sampaio; Maiara Costa Hita; Luis F Adan
Journal:  World J Diabetes       Date:  2014-10-15

4.  Increased oxidative stress in diabetic nephropathy and its relationship with soluble Klotho levels.

Authors:  A Inci; R Olmaz; F Sarı; M Coban; H Y Ellidag; M Sarıkaya
Journal:  Hippokratia       Date:  2016 Jul-Sep       Impact factor: 0.471

Review 5.  RhoA/mDia-1/profilin-1 signaling targets microvascular endothelial dysfunction in diabetic retinopathy.

Authors:  Qianyi Lu; Li Lu; Wei Chen; Haibing Chen; Xun Xu; Zhi Zheng
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-03-20       Impact factor: 3.117

6.  Genetic Deletion of NADPH Oxidase 1 Rescues Microvascular Function in Mice With Metabolic Disease.

Authors:  Jennifer A Thompson; Sebastian Larion; James D Mintz; Eric J Belin de Chantemèle; David J Fulton; David W Stepp
Journal:  Circ Res       Date:  2017-07-06       Impact factor: 17.367

Review 7.  How Can We Realize the Clinical Benefits of Continuous Glucose Monitoring?

Authors:  Ramzi A Ajjan
Journal:  Diabetes Technol Ther       Date:  2017-05       Impact factor: 6.118

8.  Organ-on-chips made of blood: endothelial progenitor cells from blood reconstitute vascular thromboinflammation in vessel-chips.

Authors:  Tanmay Mathur; Kanwar Abhay Singh; Navaneeth K R Pandian; Shu-Huai Tsai; Travis W Hein; Akhilesh K Gaharwar; Jonathan M Flanagan; Abhishek Jain
Journal:  Lab Chip       Date:  2019-07-23       Impact factor: 6.799

Review 9.  Coronary microvascular dysfunction in diabetes mellitus.

Authors:  Aleksandar Kibel; Kristina Selthofer-Relatic; Ines Drenjancevic; Tatjana Bacun; Ivica Bosnjak; Dijana Kibel; Mario Gros
Journal:  J Int Med Res       Date:  2017-01-12       Impact factor: 1.671

10.  TRAF3IP2 mediates high glucose-induced endothelin-1 production as well as endothelin-1-induced inflammation in endothelial cells.

Authors:  Jaume Padilla; Andrea J Carpenter; Nitin A Das; Hemanth Kumar Kandikattu; Susana López-Ongil; Luis A Martinez-Lemus; Ulrich Siebenlist; Vincent G DeMarco; Bysani Chandrasekar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-09-29       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.